RESEARCHER PROFILE

Thiago Rojas Converso

← Back to Universidade São Francisco

T

Universidade São Francisco

Pneumonia and Respiratory InfectionsBacterial Infections and VaccinesMicrobial infections and disease researchEscherichia coli research studiesAntimicrobial Peptides and Activities

Thiago Rojas Converso works in Pneumonia and Respiratory Infections, Bacterial Infections and Vaccines, Microbial infections and disease research, Escherichia coli research studies, Antimicrobial Peptides and Activities. Recorded institutional associations include Universidade São Francisco.

46Publications
1,005Citations
13H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Klebsiella pneumoniae Biofilms and Their Role in Disease Pathogenesis

    2022 · 267 citations
  2. Resistance Mechanisms to Antimicrobial Peptides in Gram-Positive Bacteria

    2020 · 163 citations
  3. Current Stage in the Development of Klebsiella pneumoniae Vaccines

    2021 · 138 citations
  4. Role of Streptococcus pneumoniae Proteins in Evasion of Complement-Mediated Immunity

    2017 · 85 citations
  5. The long search for a serotype independent pneumococcal vaccine

    2020 · 43 citations
  6. Combined effects of lactoferrin and lysozyme on Streptococcus pneumoniae killing

    2015 · 37 citations
  7. Animal models of Klebsiella pneumoniae mucosal infections

    2024 · 28 citations
  8. Systemic immunization with rPotD reduces Streptococcus pneumoniae nasopharyngeal colonization in mice

    2016 · 26 citations
  9. A protein chimera including PspA in fusion with PotD is protective against invasive pneumococcal infection and reduces nasopharyngeal colonization in mice

    2017 · 26 citations
  10. Recent advances in the therapeutic potential of cathelicidins

    2024 · 21 citations
  11. Influence of the Polysaccharide Capsule on the Bactericidal Activity of Indolicidin on Streptococcus pneumoniae

    2022 · 18 citations
  12. Rational selection of broadly cross-reactive family 2 PspA molecules for inclusion in chimeric pneumococcal vaccines

    2017 · 17 citations
  13. Protection Against Pneumonia Induced by Vaccination with Fimbriae Subunits from Klebsiella pneumoniae

    2025 · 16 citations
  14. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies

    2017 · 13 citations
  15. A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis

    2017 · 12 citations
  16. Protective role of PhtD and its amino and carboxyl fragments against pneumococcal sepsis

    2021 · 12 citations
  17. Pneumococcal surface protein A (PspA) prevents killing of Streptococcus pneumoniae by indolicidin

    2024 · 11 citations
  18. Immunization with PhtD truncated fragments reduces nasopharyngeal colonization by Streptococcus pneumoniae

    2020 · 10 citations
  19. In-silico and experimental analysis of Klebsiella pneumoniae fimbriae subunits for vaccine development

    2025 · 10 citations
  20. Role of the polyamine transporter PotABCD during biofilm formation by Streptococcus pneumoniae

    2024 · 8 citations
  21. Overcoming Immune Evasion in Staphylococcus aureus : Strategies for Rational Vaccine Design

    2025 · 8 citations
  22. Corrigendum: Klebsiella pneumoniae biofilms and their role in disease pathogenesis

    2025 · 7 citations
  23. A fusion protein comprising pneumococcal surface protein A and a pneumolysin derivate confers protection in a murine model of pneumococcal pneumonia

    2022 · 6 citations
  24. Immune response induced in mice by a hybrid rPotD-PdT pneumococcal protein

    2022 · 5 citations
  25. Fusion of PspA to detoxified pneumolysin enhances pneumococcal vaccine coverage

    2023 · 5 citations

← Return to the university profile